title: Diffuse involvement of the heart and great vessels in primary cardiac lymphoma.
abstract: Primary cardiac lymphoma (PCL) is an extremely rare disorder. In this report, a 57-year-old male with diffuse large B-cell lymphoma involving the heart and great vessels is presented. Trans-thoracic echocardiography was the first modality used to establish the diagnosis. Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) showed diffuse increased metabolic activity of the heart walls and hypermetabolic lesions occupying cardiac chambers in some areas. The patient underwent systemic chemotherapy, and after 13 days, a marked regression of the tumour mass was evident based on echocardiographic examination. After completing six R-CHOP chemotherapy treatments, PET imaging was planned to control the residual mass, but the patient was intubated due to pneumonia that developed after the sixth chemotherapy session and subsequently died due to sepsis.
authors.affiliation: Department of Cardiology, Uludag University Faculty of Medicine, 16059 Gorukle, Bursa, Turkey. ayselkaderli@yahoo.com
authors.forename: Aysel Aydin
authors.initials: AA
authors.lastname: Kaderli
authors.forename: Ibrahim
authors.initials: I
authors.lastname: Baran
authors.forename: Ozlem
authors.initials: O
authors.lastname: Aydin
authors.forename: Murat
authors.initials: M
authors.lastname: Bicer
authors.forename: Tayyar
authors.initials: T
authors.lastname: Akpinar
authors.forename: Fahir
authors.initials: F
authors.lastname: Ozkalemkas
authors.forename: Dilek
authors.initials: D
authors.lastname: Yesilbursa
authors.forename: Sumeyye
authors.initials: S
authors.lastname: Gullulu
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004452:Echocardiography; D017809:Fatal Outcome; D019788:Fluorodeoxyglucose F18; D006338:Heart Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000000981:diagnostic imaging* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000209:etiology; D049268:Positron-Emission Tomography; D011241:Prednisone / Q000008:administration & dosage; D000069283:Rituximab; D014057:Tomography, X-Ray Computed; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D019788:Fluorodeoxyglucose F18; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone